
Audio By Carbonatix
Some drugs taken to protect the heart may increase the risk of developing type-2 diabetes, according to researchers in Canada.Their study of 1.5 million people, in the British Medical Journal, suggested powerful statins could increase the risk by 22% compared with weaker drugs.Atorvastatin was linked to one extra case of diabetes for every 160 patients treated.Experts said the benefits of statins still outweighed any risks.Statins are a group of commonly prescribed drugs that lower the levels of bad cholesterol in the blood. This reduces the chances of a heart attack or stroke.All drugs come with side-effects, but a team of researchers from hospitals in Toronto said there had been controversy around the risk of diabetes with different statins.They looked at medical records of 1.5 million people over the age of 66 and compared the incidence of diabetes between people taking different statins.Their report said: "We found that patients treated with atorvastatin, rosuvastatin, or simvastatin were at increased risk of new onset diabetes compared with those treated with pravastatin."Clinicians should considers this risk when they are contemplating statin treatment for individual patients."Preferential use of pravastatin... might be warranted."BenefitCommenting on the study, Prof Risto Huupponen and Prof Jorma Viikari, from the University of Turku, in Finland, said: "The overall benefit of statins still clearly outweighs the potential risk of diabetes."However, they said, the different statins should be targeted at the right patients.They said: "The most potent statins, at least in higher doses, should preferably be reserved for patients who do not respond to low-potency treatment, but have a high total risk of cardiovascular disease."Maureen Talbot, from the British Heart Foundation, said: "Statins are taken safely by millions in the UK and protect those at high risk of developing coronary heart disease."Although this study suggests an increased risk of older people developing diabetes when taking certain statins, other risk factors like being overweight, family history and ethnicity may have played their part."There are benefits and risks with all medicines so if you're worried, discuss your concerns with your GP."
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Tags:
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Wave of violence kills at least 26 in Nigeria as army thwarts mass church abduction
11 minutes -
Latvian businessman Aldis Ozols enstooled as development Chief of Supresu-Man
23 minutes -
‘We should go in for the best’ – Ernest Thompson on next Black Stars coach
28 minutes -
US, Iran receive 45-day ceasefire proposal as Trump deadline to reopen Strait of Hormuz looms
41 minutes -
Iran defiant as Trump vows ‘entire country’ could be taken out if no deal reached by tonight
46 minutes -
Afigya Kwabre North crowned champions of maiden MTN Ashantifest Regional U17 football competition
47 minutes -
The case for an explicit and limited Legal threshold for internal military deployment in Ghana
48 minutes -
UK Wireless Festival sponsorship withdrawals highlight high cost of Kanye West controversy for global brands
50 minutes -
CAF President to pay working visit to Senegal over AFCON title saga
58 minutes -
GPL 2025/26: Samartex end winless run with victory over Kotoko
1 hour -
Afreximbank to avail US$10bn under its Gulf Crisis Response Programme to shield African, CARICOM economies from Middle East conflict
1 hour -
NPP behind every monumental agenda in Ghana – Miracles Aboagye
1 hour -
Ho Airport not a misplaced priority — GACL Board Chair
1 hour -
Nationwide sensitisation of haulage truck drivers ahead of Axle Load Enforcement
1 hour -
Vice President backs community tourism at Vodza Regatta 2026
1 hour